& Distribution Expenses per net sales 6.4% 6.7% (0.3%) 6.0% 6.2% (0.2%) Administrative Expense per net sales 11.1% 10.9% 0.1% 8.3% 8.2% 0.1% Net profit margin 5.1% 5.5% (0.4%) 6.9% 6.7% 0.2% - Basic earnings per

& Distribution Expenses per net sales 6.4% 6.7% (0.3%) 6.0% 6.2% (0.2%) Administrative Expense per net sales 11.1% 10.9% 0.2% 8.3% 8.2% 0.1% Net profit margin 5.1% 5.5% (0.4%) 6.9% 6.7% 0.2% - Basic earnings per

Q4 which created a decline in mobile service revenue in this quarter. Following the EBITDA movement, AIS reported a net profit of Bt6,757mn, improved 7.1% YoY from better operating performance, lower

net profit of Baht 0.8 million from its joint venture in the Philippines, Monde Malee Beverage Corporation (MMBC) in Q4/2018, the first profit making quarter of MMBC since its first operation in 2016

500,000.00 500,000.00 Total revenues 100,284.48 51,846.20 119,756.41 Net profit 17,237.13 6,390.54 9,336.77 Earnings per share (Baht) 34.47 12.78 18.67 (9) Transaction Objectives : Due to the demand from the

structure and operating which includes strategies to be consistence with economic resulting in recognized profit of company equal to 5.84 million baht which is more than recognized of loss attributable of

-103.50% Net Profit (0.34) 77.02 -100.43% Basic Earnings per Share (Baht) (0.002) 0.39 -100.43% Overall, in Q3/FY2019, the Company had net loss around 0.34 million baht, decreased around 77.35 million baht

2,010,261 3,287,211 Total shareholders’ equity 21,259,222 16,062,532 Net profit (1,145,100) (5,101,630) Earnings per share (2.86) (12.75) Number of shares 400,000 400,000 4. The meeting attendance and the

expenses Loss from fair value measurement of derivatives 17,773 7,197 15,725 - 13.02 - Net profit (loss) (3,672) (261) (1,306.90)  Revenue from sales and services decreased by 27.24%, this is due to the

administrative expenses 15,131 18,982 (20.29) Net profit (loss) 10,477 126,984 (91.75)  Sales revenue increased by 6.83% mostly from orders from overseas customers, due to the Covid-19 pandemic during Q2 which